A recent journal article on low TSH levels and bone density, directed at people on high doses of thyroid replacement hormone, is being misinterpreted by some physicians.

Valerie wrote an article investigating the problem and explains what the findings really mean [to be posted in Val's Thyroid Corner]. Unfortunately, for people on ATDs, whose guidelines state that drug monitoring is dependent on FT4 levels regardless of TSH levels, some patients are being kept hypothyroid in an effort to see TSH rise.